186
Views
8
CrossRef citations to date
0
Altmetric
Articles

Single Center Review of Clinicopathological Characterization in 77 Patients with Positive Lupus Anticoagulant Antibodies

, , , , , , , & show all
Pages 249-257 | Published online: 04 Sep 2013

References

  • Levine, J.S., M.D., Ware Branch, D. and Rauch, J. (2002) "The antiphospholipid syndrome", N. Engl. J. Med. 346(10), 752–763.
  • Brandt, J.T., Triplett, D.A., Alving, B. and Scharrer, I. (1995) "Criteria for the diagnosis of lupus anticoagulants: an update", Thromb. Haemost. 74, 1185–1190.
  • Brandt, J.T., Barna, L.K. and Triplett, D.A. (1995) "Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anti-coagulants. On behalf of the Subcommittee on Lupus Anticoagulants /Antiphospholipid Antibodies of the ISTH", Thromb. Haemost. 74, 1597–1603.
  • Tan, E.M., Cohen, AS., Fries, J.F., Masi, A.T., McShane, D.J., et al. (1982) "The revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum. 25(1982), 1271–1277.
  • Harris, E.N., Gharavi, A.E., Boey, B.M., Patel, C.G., Mockworth-Young, C.G., Loizou, S. and Hughes, G.R.V. (1983) "Anticardiolipin antibodies: detection by radio-immunoassay and association with thrombosis in systemic lupus erythematosus", Lancet 2, 1211–1214.
  • Harris, E.N., Gharavi, A.E., Patel, S.P. and Hughes, G.R.V. (1987) "Evaluation of the anti-cardiolipin antibody test: report of an international workshop held April 1986", Clin. Exp. Immunol. 68, 215–222.
  • Moll, S. and Ortel, T.L. (1997) "Monitoring warfarin therapy in patients with lupus anticoagulants", Ann. Intern. Med. 127, 177–185.
  • Creagh, M.D. and Greaves, M. (1991) "Lupus anticoagulant", Blood Rev. 5(3), 162–167.
  • Merrill, J.T. (2001) "Which antiphospholipid anti-body tests are most useful?", Rheum. Dis. Clin. N. Am. 3, 525–541.
  • Rosove, M.H. and Brewer, P.M.C. (1994) "Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients", Ann. Intern. Med. 117(4), 303–308.
  • Petri, M. (2000) "Epidemiology of the antiphospholipid syndrome", J. Autoimmune 15, 145–151.
  • Win, N., Islam, S.I., Peterldn, M.A. and Walker, ID. (1997) "Positive direct antiglobulin test due to antiphospholipid antibodies in normal healthy blood donor", Vox Sanguinis 73(3), 182–184.
  • Ravelli, A. and Martini, A. (1997) "Antiphospholipid antibody syndrome in pediatric patients", Pediatr. Rheumatol. 23(3), 657–675.
  • Rodriguez, F.J.M., Reverter, J.C., Font, J., Tassies, D., Cervera, R., et al. (2000) "Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome", Haematologica 85(6), 632–637.
  • Segovia, D.A., Deleze, M., Oria, C.V., Guerrero, J.S., Pacheco, L.G., et al. (1989) "Antiphospholipid antibodies and the antiphopholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients", Medicine 68(6), 353–362.
  • Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., et al. (2002) "Antiphospholipid syndrome", Arthritis Rheum. 46(4), 1019–1027.
  • Asheron, R.A., Cervera, R., Piette, J.C., Font, J. and Lie, J.T. (1998) "Catastrophic antiphospholipid syndrome: clinical laboratory features of 50 patients", Medicine 77, 195–207.
  • Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. and Hughes, G.R.V. (1995) "The management of thrombosis in the antiphospholipid-antibody syndrome", N. Engl. J. Med. 332(15), 993–997.
  • McNeil, H.P., Chesterman, C.N. and Krilis, S.A. (1991) "Immunology and clinical importance of antiphospholipid antibodies", Adv. Immunol. 49, 193–280.
  • Vianna, J.L., Khamashta, M.A., Ordi-Ros, J., Font, J., Cervera, R., et al. (1994) "Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients", Am. J. Med. 96(1), 3–9.
  • Marai, I., Levi, Y., Godard, G. and Shoenfeld, Y. (2001) "Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population", Harefuah 140(6), 495–500, 565.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.